AI governance in healthcare: what controls do teams actually need?

TL;DR: Its move into DHDP reflects a broader push to scale AI in healthcare with governance, compliance, and accountability built in, not bolted on after deployment, according to Asenion. The practical issue is that regulated AI programmes fail when trust, oversight, and lifecycle controls lag behind experimentation.

Editorial analysis by NHI Mgmt Group, based on content published by Asenion: “Asenion Joins DHDP to Power the Future of AI in Healthcare”.

Key questions

Q: How should healthcare organisations govern AI when data comes from many systems?

A: Healthcare organisations should govern AI by treating data provenance, access, and workflow ownership as a single control plane.

Q: Why do AI governance committees matter when models are used in patient care?

A: AI governance committees matter because clinical AI changes workflow, risk, and accountability across multiple teams.

Q: What breaks when AI agent data access is not tied to identity governance?

A: What breaks is accountability.

Practitioner guidance

• Define AI approval gates before production use Require every healthcare AI use case to pass a documented approval path that covers purpose, data scope, risk level, and accountable owner before deployment.
• Map AI system access to named identities Tie training data access, model administration, and deployment permissions to specific human and non-human identities so that every privileged action is attributable.
• Classify models by clinical and compliance risk Use a repeatable risk classification step so that higher-stakes models receive stricter review, monitoring, and change control than low-impact use cases.

Bottom line: AI governance in healthcare only works when approval, monitoring, and accountability are embedded into deployment workflows.

Explore further

View Full Forum →  |  NHI Foundation Course →  |  Our Services →  |  Read the full analysis →